Home

Ashley McEvoy

CIK 1745936 · President and CEO · last filed 2026-08-24

Ashley McEvoy is a President and CEO who has filed 34 SEC Form 4 insider transactions across 4 companies since 2018. The most recent filing shows the insider bought $162.2K of PODD on Aug 24, 2026. Across all open-market trades the lifetime net is −$16.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $21.5M across reported positions. 17 SEC filings were submitted jointly with & JOHNSON JOHNSON.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$21.52M

Companies

4

Total Filings

34

Lifetime Open-Market Net

-$15.95M

Filer Profile

Reported Address
THE PROCTER & GAMBLE COMPANY
ONE PROCTER & GAMBLE PLAZA
CINCINNATI, OH 45202
Related Filers
& JOHNSON JOHNSON — 17 joint filings, latest 2024-02-09
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PODD President and CEO 23,735 $147.48 $3.50M $1.19M 5 2026-08-24
PG Director 5,986 $146.44 $876.6K $0 13 2026-06-10
JOHNSON & JOHNSON (JNJ.WD) Delisted EVP, WW Chair, MedTech 52,337 — — $0 1 2023-08-25
JNJ EVP, WW Chair, MedTech 62,282 $275.23 $17.14M -$17.14M 13 2023-02-15

Recent Filings

34 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-08-24 PODD Buy (P) +1,100 $162.2K EDGAR
2026-06-10 PG Grant (A) +202 $0 EDGAR
2026-05-15 PODD Tax (F) −1,411 -$210.0K EDGAR
2026-03-11 PG Grant (A) +161 $0 EDGAR
2026-02-26 PODD Grant (A) +10,046 $0 EDGAR
2026-02-23 PODD Buy (P) +4,300 $1.03M EDGAR
2025-12-10 PG Grant (A) +215 $0 EDGAR
2025-10-15 PG Grant (A) +1,475 $0 EDGAR
2025-09-10 PG Grant (A) +189 $0 EDGAR
2025-06-11 PG Grant (A) +185 $0 EDGAR
Showing 1–10 of 34
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.